Big Black Heart Image | kbDNA

DITCH OUTDATED LAB TOOLS

Reinforce your R&D with Optimized BioReagents

Optimized synthesis cuts through today’s market risks and inefficiencies. In-house reagents bypass legacy production bottlenecks and resale markups, allowing scientists to focus more on research than procurement

A row of empty bottles with orange lids on a white background.

BYPASS THE COMPLEXITY OF RUO

Eliminate barriers in qualifying reagents

Match your specs with thousands of ready-to-ship analyte-specific (ASR's) reagents, optimized in various formats to fit an array of R&D applications.

A gray and blue ribbon is floating in the air

Control your workflow

kb's ASRs; oligos, and recombinants outperform legacy systems in QC and application—raising the bar in RUO. It’s a smarter platform that simplifies how labs find and buy reagents, eliminating the usual headaches and inefficiencies.

Solutions that scale with your science

Over 80% of preclinical studies face reproducibility issues. kbDNA delivers research-grade reagents with lot-to-lot consistency, ensuring reliable results. Unlike add-to-cart suppliers or third-party distributors, kbDNA has the in-house capacity to tailor formulation and production, supporting your path from discovery through scale-up.

Discover the technology

Expand manufacturing with automation and versatility

Standard production methods have not changed in decades. Many are manual and difficult to upgrade. Our focus has been on optimizing traditional methods via automation. This utilizes ancillary reagents and compounds at specific production points, identified by data metrics.

Start Smarter—Download the kbDNA Solutions Handbook

Explore how kbDNA is redefining reagent quality, automation, and consistency in life science research. From custom RUO reagents to scalable manufacturing and advanced QC, our Solutions Handbook details the tools, technologies, and insights that power reproducible results.

Get your copy

Introducing our Optimized Reagents

We’ve redefined what research reagents should be. Our Optimized Bioreagents—including oligonucleotides, recombinant proteins, and antibodies—are engineered for superior quality, seamless scalability, and effortless integration into your workflows.

A man in a lab coat is standing in a room with boxes on the ceiling. kbDNA recombinant proteins buy

Measuring against the standard

A gray and blue ribbon is floating in the air
A row of bottles with blue lids on a white background.

BETTER DATA IS ALWAYS BETTER SCIENCE

kbDNA is Upping the Standard in Certificate QC

qc tests for reagents. advanced highest rank

Peace of Mind Starts with Proven Materials

Every reagent undergoes rigorous, multi-tiered QC—far beyond industry norms. From structural validation to advanced purity profiling, our standards ensure unmatched consistency, reliability, and peace of mind in every lot.


RUO

Versatile Synthesis & Ready-to-ship Products

$0 Cost. 0 Downtime. 0 Confusion.

Transitioning to Optimized Reagents Is Cost-Free.

Switching to Optimized Reagents is simple. They drop into your workflow with zero friction—no recalculating, no protocol changes. Use them just like your standard reagents and unlock better performance, instantly.

Switching to Optimized Reagents is simple. They drop into your workflow with zero friction—no recalculating, no protocol changes. Use them just like your standard reagents and unlock better performance, instantly.

A picture of a protocol and a picture of a test tube. kbDNA
A black banner with a list of kbDNA features on it
A row of empty bottles with blue lids on a white background.

Support your decision with literature.

Gain insight from our product docs, technology articles, and support resources—all in one place to help you make confident, informed decisions.

PubLab |  Publishing Lab

A green and purple background with a pattern of flowers on it.

Biosimilars: Navigating the Landscape for Future Therapeutics

By Vaibhav Shah • May 17, 2025
This article explores the complexities of biosimilars, including their development process, regulatory challenges, economic impact, and future prospects. It highlights the potential of biosimilars to reduce healthcare costs and increase patient access to biologic therapies, providing valuable insights for biopharmaceutical and academic researchers.
A row of beakers filled with colorful liquids in front of a city skyline.

JPM 52:25

By Ed Hamdeh • January 7, 2025
Explore key insights and major trends from a decade of JPM Biotech conferences. Download our exclusive 2025 prospectus for the latest in biotech deals and innovations.
A computer generated image of a cell with a purple and orange background.

FLAG Tag: A Comprehensive Overview for Biopharmaceutical Research

By Ed Hamdeh • October 25, 2024
The FLAG tag (DYKDDDDK) is an epitope tag widely utilized in biopharmaceutical research for protein purification, detection, and functional analysis. This article provides an in-depth examination of FLAG tag technology, its advantages, limitations, and diverse applications. Additionally, it explores current research trends and future directions in FLAG tag technology, making it a pivotal tool in advancing drug discovery and development.

Advancing With Peptide Synthesis

October 2, 2024
Discover the latest advancements in peptide synthesis at kbDNA. Learn about innovative techniques, optimized reagents, and cutting-edge technologies that enhance research efficiency and outcomes.

ResLib |  Resource Library

Peptide Preparation Guide and Protocols | kbDNA

Peptide Preparation Guide (+Protocols)

By Ed Hamdeh • August 20, 2024
Discover essential tips and protocols for handling and preparing synthesized peptide sequences. Learn how to tailor your approach to the unique characteristics of your peptides to ensure successful outcomes in your research
Microarray_2023 kbdna

Microarrays Revisited [2025]

By Dr. Nandana Bhardwaj • January 6, 2023
Microarray is a versatile and high-throughput method to explore genome and parallel genes data sets with unpredictable functions & variety of samples. After kb original protocol, this version dives deeper into the newer experiment challenges and provides an updated copy to help your experiments
Abstract Image, kbdna

Bioconjugation Chemistry: Challenges and Solutions

By Ed Hamdeh, PD • December 1, 2022
Examples of bioconjugation based hybrid molecules include protein structure elucidation using tags, enzyme immobilization, antibodies binding to fluorophores, cellular imaging, microarrays, etc.

ENDORSED IN PRACTICE

Our clients success is our success.

A close up of blue ink in water on a white background.

Dual-labeled qPCR probes

“We needed dual-labeled probes that just worked. In other words; clean signal, no background, and consistent across lots. KbDNA delivered exactly that. Their probes helped us lock in assay performance and move into clinical validation without delays.”

Two small bottles are sitting on top of a piece of paper.

Scaling ELISA Assay Development

“We needed reliable proteins to finalize our ELISA kit. KbDNA’s IL-6 and TNF-α were not only pure and active, but they also delivered consistent performance across lots. That kind of reliability is rare—and it saved us a ton of time in validation.”

Modified oligos manufacturing

“Scaling from 100 nmol to 10 µmol with complex modifications was a nightmare, until we found KbDNA. They nailed the synthesis, QC, and even helped us tweak our formulation buffer. We’re now shipping pilot batches with confidence.”

kb's Biosimilars..GMP without the price tag!

“We were approaching a critical inflection point—transitioning our RUO-grade biologics for the VEGF program into preclinical studies. KbDNA provided a near-GMP quality recombinant protein that met our purity and consistency requirements without the overhead of full GMP sourcing. We're talking almost a kilogram of material here. Their responsiveness and technical documentation helped us align with our CMC strategy and working with them has kept us on timeline so far.”

CRISPR with sgRNAs

“We were running a genome-wide CRISPR screen and kept hitting variability in editing efficiency. KbDNA’s sgRNAs were a game-changer. Especially their full QC. We got reproducible knockouts across replicates and wrapped the screen weeks ahead of schedule.”

Dual-labeled qPCR probes

“We needed dual-labeled probes that just worked. In other words; clean signal, no background, and consistent across lots. KbDNA delivered exactly that. Their probes helped us lock in assay performance and move into clinical validation without delays.”

DISCLAIMER: The contents in this section were collected or provided with consent by the respective customer and is being shared to the limit specified by each individual account. No referal solicitation or resale of client details permitted.

A start-to-finish solution: from sample to scale-up.

Our product takes your research oligos or key proteins from their exploration through validation and into scale-up demand via a sole tailored platform

Start Rescuing Your R&D from Outdated Tools.

Whether exploring a new pathway or scaling-up,
we're here to help you move faster and smarter